Consistent with these complementation studies, expression of SMARCA2-associated genes was downregulated and cell growth of SMARCA4-mutant lung cancers was impaired upon inhibition of the ATPase domain with the SMARCA2/4 ATPase inhibitor 14 [74]. This evidence concerns the gene SMARCA4 and lung cancer.